|
US7122189B2
(en)
*
|
2002-08-13 |
2006-10-17 |
Enzon, Inc. |
Releasable polymeric conjugates based on aliphatic biodegradable linkers
|
|
US7413738B2
(en)
*
|
2002-08-13 |
2008-08-19 |
Enzon Pharmaceuticals, Inc. |
Releasable polymeric conjugates based on biodegradable linkers
|
|
US7087229B2
(en)
*
|
2003-05-30 |
2006-08-08 |
Enzon Pharmaceuticals, Inc. |
Releasable polymeric conjugates based on aliphatic biodegradable linkers
|
|
US7332164B2
(en)
*
|
2003-03-21 |
2008-02-19 |
Enzon Pharmaceuticals, Inc. |
Heterobifunctional polymeric bioconjugates
|
|
MXPA05011022A
(es)
*
|
2003-04-13 |
2006-04-27 |
Enzon Pharmaceuticals Inc |
Profarmacos oligonucleotidos polimericos.
|
|
SI1625156T1
(sl)
|
2003-05-12 |
2013-02-28 |
Affymax, Inc. |
Peptidi, ki se veĹľejo k eritropoetinskemu receptorju
|
|
WO2004100997A2
(en)
*
|
2003-05-12 |
2004-11-25 |
Affymax, Inc. |
Spacer moiety for poly(ethylene glycol) -modified peptides
|
|
JP4266028B2
(ja)
|
2003-05-12 |
2009-05-20 |
アフィーマックス・インコーポレイテッド |
エリスロポエチン受容体に結合する新規ペプチド
|
|
CZ294996B6
(cs)
*
|
2003-07-16 |
2005-04-13 |
Ústav Makromolekulární Chemie Av Čr |
Reaktivní polymery a kopolymery na bázi N-(2-hydroxypropyl)methakrylamidu, způsob jejich přípravy a jejich použití pro syntézu polymerních léčiv, pro modifikaci biologicky aktivních proteinů a přípravu systémů pro dopravu genů
|
|
US8394365B2
(en)
|
2003-09-17 |
2013-03-12 |
Nektar Therapeutics |
Multi-arm polymer prodrugs
|
|
ES2629696T3
(es)
*
|
2003-09-17 |
2017-08-14 |
Nektar Therapeutics |
Profármacos poliméricos multibrazo
|
|
MXPA06010782A
(es)
*
|
2004-03-23 |
2007-03-28 |
Complex Biosystems Gmbh |
Ligador de profarmaco.
|
|
US7365127B2
(en)
*
|
2005-02-04 |
2008-04-29 |
Enzon Pharmaceuticals, Inc. |
Process for the preparation of polymer conjugates
|
|
US7550433B2
(en)
|
2005-06-03 |
2009-06-23 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
|
GB2427360A
(en)
*
|
2005-06-22 |
2006-12-27 |
Complex Biosystems Gmbh |
Aliphatic prodrug linker
|
|
EP2089052A4
(en)
*
|
2006-05-24 |
2011-02-16 |
Peg Biosciences |
POLYETHYLENE GLYCOL-BASED LINK COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES BASED ON SAID COMPOUNDS
|
|
RU2424246C2
(ru)
*
|
2006-05-26 |
2011-07-20 |
Ипсен Фарма С.А.С. |
Способы сайт-специфического пегилирования
|
|
US20090156629A1
(en)
*
|
2006-06-09 |
2009-06-18 |
Enzon Pharmaceuticals, Inc. |
Indenoisoquinoline-releasable polymer conjugates
|
|
MX2009000284A
(es)
*
|
2006-06-30 |
2009-01-26 |
Enzon Pharmaceuticals Inc |
Hospedero recombinante para produccion de l-asparaginasa ii.
|
|
JP2010503706A
(ja)
*
|
2006-09-15 |
2010-02-04 |
エンゾン ファーマスーティカルズ インコーポレイテッド |
リジン系ポリマーリンカー
|
|
MX2009002855A
(es)
*
|
2006-09-15 |
2009-03-30 |
Enzon Pharmaceuticals Inc |
Profarmacos polimericos dirigidos que contienen enlazadores multifuncionales.
|
|
TW200836762A
(en)
*
|
2006-11-27 |
2008-09-16 |
Enzon Pharmaceuticals Inc |
Polymeric short interfering RNA conjugates
|
|
CN101583380B
(zh)
|
2006-11-30 |
2013-07-10 |
尼克塔治疗公司 |
用于制备聚合物轭合物的方法
|
|
CA2670618C
(en)
|
2006-12-15 |
2016-10-04 |
Baxter International Inc. |
Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life
|
|
CA2671209A1
(en)
*
|
2006-12-29 |
2008-07-10 |
Enzon Pharmaceuticals, Inc. |
Use of adenosine deaminase for treating pulmonary disease
|
|
US8106154B2
(en)
|
2007-01-31 |
2012-01-31 |
Affymax, Inc. |
Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
|
|
HUE027603T2
(en)
*
|
2007-04-20 |
2016-10-28 |
Sigma-Tau Rare Disease Ltd |
Stable, recombinant adenosine deaminase
|
|
EP2147122B1
(en)
*
|
2007-04-20 |
2014-07-16 |
Sigma-Tau Rare Diseases S.A. |
Enzymatic anticancer therapy
|
|
ES2617737T3
(es)
*
|
2007-06-26 |
2017-06-19 |
Baxalta Incorporated |
Procedimiento de preparación de enlazadores hidrolizables basados en Fmoc
|
|
WO2009025669A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Enzon Pharmaceuticals, Inc. |
Polymeric linkers containing pyridyl disulfide moieties
|
|
KR101671537B1
(ko)
|
2008-08-11 |
2016-11-01 |
넥타르 테라퓨틱스 |
다분지형 중합체 알카노에이트 컨쥬게이트
|
|
HUE047352T2
(hu)
|
2008-09-23 |
2020-04-28 |
Nektar Therapeutics |
Eljárás ütemezett beadásra kamptotecin elõgyógyszerekkel (például PEG-ironotekánnal)
|
|
CA2740904C
(en)
*
|
2008-10-21 |
2019-01-15 |
Baxter International Inc. |
Methods for determining active ingredients in pro-drug peg protein conjugates with releasable peg reagents (in vitro de-pegylation)
|
|
CN102497884A
(zh)
|
2009-07-27 |
2012-06-13 |
巴克斯特国际公司 |
凝血蛋白缀合物
|
|
KR101912335B1
(ko)
|
2009-07-27 |
2018-10-26 |
리폭센 테크놀로지즈 리미티드 |
비혈액 응고 단백질의 글리코폴리시알화
|
|
US8809501B2
(en)
|
2009-07-27 |
2014-08-19 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
|
CN106110311A
(zh)
|
2009-07-27 |
2016-11-16 |
百深公司 |
凝血蛋白缀合物
|
|
US8642737B2
(en)
|
2010-07-26 |
2014-02-04 |
Baxter International Inc. |
Nucleophilic catalysts for oxime linkage
|
|
KR101831685B1
(ko)
*
|
2010-01-25 |
2018-02-23 |
롬 앤드 하스 일렉트로닉 머트어리얼즈 엘엘씨 |
질소-함유 화합물을 포함하는 포토레지스트
|
|
US10894087B2
(en)
|
2010-12-22 |
2021-01-19 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
|
WO2012088422A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
|
HUE049352T2
(hu)
|
2010-12-22 |
2020-09-28 |
Baxalta GmbH |
Anyagok és módszerek egy vízoldható zsírsavszármazéknak egy fehérjéhez való konjugálására
|
|
KR20140053991A
(ko)
|
2011-07-18 |
2014-05-08 |
아츠 바이올로직스 에이/에스 |
장기간 작용하는 황체 형성 호르몬 (lh) 화합물
|
|
US8962577B2
(en)
*
|
2012-03-16 |
2015-02-24 |
The Johns Hopkins University |
Controlled release formulations for the delivery of HIF-1 inhibitors
|
|
JP6138904B2
(ja)
*
|
2012-03-16 |
2017-05-31 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
|
|
WO2013167750A2
(en)
|
2012-05-11 |
2013-11-14 |
Prorec Bio Ab |
Method for diagnosis and treatment of prolactin associated disorders
|
|
CN103881083A
(zh)
*
|
2012-12-21 |
2014-06-25 |
张雅珍 |
含有蒽环类抗生素结构的新化合物以及制备方法和用途
|
|
CN103897176B
(zh)
*
|
2012-12-24 |
2018-08-17 |
张雅珍 |
蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用
|
|
CN103897178A
(zh)
*
|
2012-12-24 |
2014-07-02 |
张雅珍 |
含有蒽环类抗生素结构的新化合物以及制备方法和用途
|
|
CN103910871A
(zh)
*
|
2012-12-28 |
2014-07-09 |
张雅珍 |
蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用
|
|
CN103910870B
(zh)
*
|
2012-12-28 |
2018-08-17 |
张雅珍 |
蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用
|
|
CN103910866B
(zh)
*
|
2012-12-31 |
2018-08-17 |
张雅珍 |
含有蒽环类抗生素结构的新化合物以及制备方法和用途
|
|
PL2968440T3
(pl)
|
2013-03-15 |
2019-12-31 |
Zymeworks Inc. |
Związki cytotoksyczne i antymitotyczne oraz sposoby ich stosowania
|
|
RU2729194C2
(ru)
|
2013-12-27 |
2020-08-05 |
Займворкс Инк. |
Сульфонамидсодержащие связывающие системы для лекарственных конъюгатов
|
|
US10946096B2
(en)
|
2014-02-26 |
2021-03-16 |
The Board Of Regents Of The University Of Texas System |
Nitrobenzaldehyde proton release for manipulation of cellular acidosis
|
|
AU2015318556C1
(en)
|
2014-09-17 |
2021-01-07 |
Zymeworks Bc Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
ES2753391T3
(es)
|
2014-10-14 |
2020-04-08 |
Halozyme Inc |
Composiciones de adenosina desaminasa 2 (ADA2), variantes de la misma y métodos de uso de las mismas
|
|
KR102666366B1
(ko)
|
2015-04-24 |
2024-05-20 |
듀크 유니버시티 |
영상화제로 유용한 비스포스포네이트 또는 파이로포스페이트와의 금속 착물
|
|
NZ743487A
(en)
|
2016-01-08 |
2023-02-24 |
Ascendis Pharma Growth Disorders As |
Controlled-release cnp agonists with increased nep stability
|
|
MX2018008061A
(es)
|
2016-01-08 |
2018-08-23 |
Ascendis Pharma Growth Disorders As |
Profarmacos de peptido natriuretico tipo c (cnp) con porciones portadoras grandes.
|
|
IL297375B2
(en)
|
2016-01-08 |
2024-02-01 |
Ascendis Pharma Growth Disorders As |
Controlled-release CNP agonists with low NPR–C binding
|
|
WO2017118707A1
(en)
|
2016-01-08 |
2017-07-13 |
Ascendis Pharma Growth Disorders A/S |
Controlled-release cnp agonists with reduced side-effects
|
|
LT3400019T
(lt)
|
2016-01-08 |
2022-12-12 |
Ascendis Pharma Growth Disorders A/S |
Cnp provaistai su prie žiedo fragmento prijungtu nešikliu
|
|
IL259827B2
(en)
|
2016-01-08 |
2025-07-01 |
Ascendis Pharma Growth Disorders As |
Controlled-release CNP agonists with low initial NPR-B activity
|
|
MX2018009938A
(es)
|
2016-03-01 |
2019-03-14 |
Ascendis Pharma Bone Diseases As |
Profarmacos de hormona paratiroidea (pth).
|
|
CN109789189B
(zh)
|
2016-09-29 |
2024-01-23 |
阿森迪斯药物骨疾病股份有限公司 |
控释pth化合物的剂量方案
|
|
MA46428B1
(fr)
|
2016-09-29 |
2025-02-28 |
Ascendis Pharma Bone Diseases A/S |
Composés de pth à libération contrôlée
|
|
EP3518961B1
(en)
|
2016-09-29 |
2023-02-22 |
Ascendis Pharma Bone Diseases A/S |
Pth compounds with low peak-to-trough ratios
|
|
HUE062117T2
(hu)
|
2016-09-29 |
2023-09-28 |
Ascendis Pharma Growth Disorders As |
Kombinációs terápia szabályozott felszabadulású CNP agonistákkal
|
|
CN108530637B
(zh)
*
|
2017-03-05 |
2021-03-30 |
厦门赛诺邦格生物科技股份有限公司 |
一种单一功能化支化聚乙二醇的制备方法
|
|
WO2019016240A1
(en)
|
2017-07-19 |
2019-01-24 |
Leadiant Biosciences Ltd |
ADENOSINE DEAMINASE FOR TREATING OR IMPROVING SCLERRODERMIS ASSOCIATED VASCULOPATHY
|
|
WO2019185705A1
(en)
|
2018-03-28 |
2019-10-03 |
Ascendis Pharma A/S |
Il-2 conjugates
|
|
WO2020064847A1
(en)
|
2018-09-26 |
2020-04-02 |
Ascendis Pharma A/S |
Degradable hyaluronic acid hydrogels
|
|
CA3129357A1
(en)
|
2019-02-11 |
2020-08-20 |
Ascendis Pharma Bone Diseases A/S |
Liquid pharmaceutical formulations of pth conjugates
|
|
EP3923906A1
(en)
|
2019-02-11 |
2021-12-22 |
Ascendis Pharma Growth Disorders A/S |
Dry pharmaceutical formulations of cnp conjugates
|
|
MX2022014082A
(es)
|
2020-06-03 |
2022-12-07 |
Ascendis Pharma Oncology Div A/S |
Secuencias de interleucina (il-2) y usos de las mismas.
|